XML 30 R17.htm IDEA: XBRL DOCUMENT v3.25.2
WARRANT LIABILITY
6 Months Ended
Jun. 30, 2025
Warrant Liability  
WARRANT LIABILITY

7. WARRANT LIABILITY

 

On February 3, 2025, the Company entered into a new Securities Purchase Agreement (the “2025 Purchase Agreement”) with an institutional investor. In exchange for $8.0 million, the Holder agreed to purchase 5,750,225 shares of common stock (the “closing shares”) and warrants to purchase up to 5,750,225 shares of common stock at an exercise price of $1.57 per share (the “warrants”). On February 4, 2025, the 2025 Purchase Agreement closed for net proceeds of approximately $7.8 million, inclusive of all fees and expenses related to the transaction. The warrants are exercisable beginning August 4, 2025 and expire on August 4, 2030. There have been no exercises of warrants as of June 30, 2025.

 

The warrants are accounted for as a liability under ASC 480, Distinguishing Liabilities from Equity. Both the closing shares and the warrants are initially recorded on February 4, 2025 at their fair values of $9.0 million and $6.3 million, respectively. The warrant liability is subsequently remeasured and reported at fair value each reporting period, with the changes in fair value recorded as an unrealized gain or loss and recognized in earnings.

 

The fair value of warrants as of June 30, 2025 and December 31, 2024 are as follows:

 

   June 30,   December 31, 
(in thousands)  2025   2024 
Warrant liability  $3,733   $- 
Total  $3,733   $- 

 

Unrealized gains and losses associated with warrants are as follows:

 

(in thousands)  2025   2024   2025   2024 
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
(in thousands)  2025   2024   2025   2024 
Unrealized gain (loss) on warrant liability  $803   $-   $2,564   $- 

 

Interest expense of $7.3 million representing the discount on the transaction was recorded on the condensed consolidated financial statements for the six months ended June 30, 2025.

 

The valuation inputs hierarchy classification for liabilities measured at fair value on a recurring basis are summarized below as of June 30, 2025 and December 31, 2024 (in thousands). See Note 5. Investment Securities, Available-For-Sale and Fair Value Measurements, for discussion of the fair value level hierarchy.

 

As of June 30, 2025  Level 1   Level 2   Level 3 
Warrant liability  $-   $-   $3,733 
Total  $-   $-   $3,733 

 

 

As of December 31, 2024  Level 1   Level 2   Level 3 
Warrant liability  $-   $-   $- 
Total  $-   $-   $- 

 

The fair value of the warrants is measured using the Black-Scholes option pricing model as of the measurement dates. The table below lists the inputs and assumptions for the Company’s valuations as of June 30, 2025 and upon initial measurement as of February 4, 2025:

 

   June 30,   February 4, 
   2025   2025 
Expected term (years)   5.1    5.5 
Risk-free interest rate   3.80%   4.34%
Dividend yield   0%   0%
Volatility   71.97%   80.14%